Clinical 2021 - Amazon Web Services

LGC Proficiency Testing, 1 Chamberhall Business Park, Chamberhall Green, Bury, BL9 0AP, UK. Telephone: + 44 (0) 161 762 2500

E-mail: [email protected], Website: www.lgcstandards.com

of 20 V4

Clinical 2021 Proficiency Testing Schemes

Application Form

INDEX

Other samples of interest exist in other schemes, most notably: 1. QUARTZ - test materials aimed primarily aimed at Forensic Toxicology Laboratories, includes numerous materials including Novel Psychoactive Substances (NPS) and synthetic cannabinoids. 2. Drugs of Abuse in Hair. For information relating to these schemes and test materials please contact your local office/distributor.

A2LA-accredited programs are managed from LGC Proficiency Testing in Traverse City, Michigan, USA. UKAS accredited programs are managed from LGC Proficiency Testing in Bury, UK. Exceptions to accreditation are noted. Not all programs are accredited and accredited programs are included in either UKAS or A2LA accreditation. See both scopes of accreditation online for details.

HOW TO REGISTER ………………………………………………………………………………….. 2

YOUR DETAILS …….………………………………………………………………………………….. 2

SAMPLES AVAILABLE

PACKAGE OFFERS ……...…………………………………………………………………… 3

CHEMISTRY …………..……………………………………………………………………….. 3 - 4

HAEMATOLOGY ………………………………………………………………………………. 5

IMMUNOLOGY …..…………………………………………………………………………….. 6

BACTERIOLOGY ……………………………………………………………………………… 7 - 8

MYCOBACTERIOLOGY ……………………………………………………………………… 8

MYCOLOGY …………………………………………………………………………………… 8

PARASITOLOGY …………….………………………………………………………………... 9

VIROLOGY ………………………..…………………………………………………………… 9

MOLECULAR MULTIPLEX .………………………………………………………………….. 10

THERAPEUTIC DRUGS ...……………………………………………………………………. 10 - 11

DRUGS FOR THE TREATMENT OF SUBSTANCE RELATED DISORDERS ………… 11

PSYCHOACTIVE DRUGS ……………………………………………………………………. 11 - 13

PSYCHOSTIMULANTS ………………………………………………………………………. 13

SMOKING RELATED DRUGS ………………………………………………………………. 13

ANTI-HYPERTENSIVE DRUG SCREEN …………………………………………………… 14

ANTIBIOTIC AND ANTIFUNGAL DRUGS …………………………………………………. 14

IMMUNOSUPPRESSANTS ………………………………………………………………….. 15

TOXICOLOGY …………………………………………………………………………………. 15 - 16

DRUG OF ABUSE IN URINE ………………………………………………………………… 16

DRUGS OF ABUSE IN ORAL FLUID ……………………………………………………….. 16

SHIPPING DATES ……………………………………………………………………………………... 17 – 10

REPEAT/ADDITIONAL PRICES ……………………………………………………………………... 19

GENERAL NOTES …………………………………………………………………………………….. 20



of 20 V4


Application Form

HOW TO REGISTER

1. Complete ‘Your Details’ section on page 2. 2. Mark the required samples on pages 3 – 16. 3. Return the completed application form to us via email: [email protected]

For details on the full technical specification of the scheme, please refer to the Scheme Description. Please ensure that LGC receive your order as soon as possible in order to avoid stock shortages. Please note that orders received the week prior to the despatch date may be subject to a despatch delay.

YOUR DETAILS

Send Test Materials to: Send Invoices to:

Contact name: Contact name: Department: Department: Company: Company: Address: Address: Town/City: Town/City: Post/Zip Code: Post/Zip Code: Country: Country: Tel: Tel: Fax: Fax: E-mail: E-mail: VAT no:

Send Report Notifications to: #An email will be sent to this address to notify when the report is available to download from PORTAL, the online reporting system

Contact name:

E-mail#:

Existing customers If you would like to change your marketing preferences, please visit our preference centre or contact [email protected] New customers LGC would like to contact you by email, phone or post about its products, services and related areas or research. LGC does not sell contact details to external parties. You may unsubscribe at any time.

Yes, I am happy to be contacted about LGC’s products, services and research

No, I do not require marketing information about LGC’s products and services at this time

By signing this application form, you are agreeing to comply by LGC’s Standard Terms and Conditions for the Supply of Laboratory Quality Products and Services and are agreeing that you have read and agree to the ‘General Notes’ at the end of this document. Furthermore, for test samples containing microorganisms with a bio safety level (BSL) of 1 or 2, you are confirming that you are complying with applicable laws and regulations when using such materials.

Name ……………………………………… Date ……………………

Returning customer Lab ID: Purchase order no.: (compulsory)

_ _ _ _ _ _

https://www2.lgcgroup.com/l/31922/2014-11-03/k17ft

mailto:[email protected]



of 20 V4


Application Form

SAMPLES AVAILABLE

PACKAGE OFFERS (CLS)

Order one of our packages to benefit from a 40% discount. Please see the programme listing in the relevant section of the application form for full analyte details.

CHEMISTRY (CLS) ACCREDITED BY A2LA

Package Programmes included Please tick

1 CHM Chemistry/Immunoassay (1-20 analytes) BHM Basic Haematology UA Urinalysis and HCG

2

CHM Chemistry/Immunoassay (21-30 analytes) BHM Basic Haematology UA Urinalysis and HCG GLH Glycosylated Haemoglobin

3

CHM Chemistry/Immunoassay (31+ analytes) BHM Basic Haematology UA Urinalysis and HCG GLH Glycosylated Haemoglobin COA Coagulation (6+ analytes)

Sample Target Analyte(s) Supplied as Rounds per annum Number

of analytes

Please tick

PT-CL-CC-CHM

Chemistry / Immunoassay There are three levels of participation. Please see ‘Price’ column for further details. Analytes can be chosen from Chemistry, TDM and/or Immunoassay sections of the CHM sample. Participants select chosen analytes at the point of results entry.

Chemistry analytes: ACE; Acid Phosphatase, total; Albumin; Alkaline Phosphatase (ALP); ALT; Amylase, pancreatic; Amylase, total; AST; Bicarbonate; Bile Acid; Bilirubin, direct; Bilirubin, indirect; Bilirubin, total; Calcium, ionised; Calcium, total; Chloride; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, total; Cholinesterase; Copper; Creatine Kinase (CK); Creatinine; D-3-Hydroxybutyrate; Fructosamine; GGT; GLDH; Glucose; HBDH; Iron; Lactate; LDH; Lipase; Magnesium; NEFA; Osmolality; Phosphate; Potassium; Protein, total; Sodium; T Uptake (%); T Uptake (units); T3, free; T4, free; Thyroxine (T4); TIBC (measured or iron-based calc.); Triglycerides; Triiodothyronine (T3); TSH; UIBC; Urate; Urea; Zinc

TDM analytes: Amikacin; Carbamazepine; Digoxin; Gentamicin; Lithium; Paracetamol (Acetaminophen); Phenobarbital; Phenytoin; Salicylic Acid; Theophylline; Tobramycin; Valproate; Vancomycin

Immunoassay analytes: 11-Deoxycortisol; 17-OH-Progesterone; Aldosterone; Alpha-fetoprotein (AFP); Androstenedione; CEA; Cortisol; DHEA Sulfate; DHEA, unconjugated; Ferritin; Folate; Follicle Stimulating Hormone; Growth Hormone (hGH); hCG; LH; Oestradiol; Oestriol, free (UE3); Oestriol, total; PAP; Prealbumin; Progesterone; Prolactin; PSA, total; SHBG; Testosterone, free; Testosterone, total; TIBC (transferrin-based calculation); Thyroxine Binding Globulin (TBG); Transferrin; Vitamin B12

5ml lyophilised serum

12 rounds (2 despatches,

6 rounds per despatch)

1 - 20

analytes

21 - 30

analytes

31+

analytes



of 20 V4


Application Form



Sample Target Analyte(s) Supplied as Rounds per annum Please tick

PT-CL-CC-ALM

Alcohol/Ammonia Acetone (Ketones); Ethanol; Ammonia

2ml serum 12 rounds (3 despatches,


PT-CL-CC-IAS

Immunoassay - Special

1-25-(OH)2 Vitamin D; 25-OH Vitamin D; ACTH; Calcitonin; C-peptide; Gastrin; IGF-1; Insulin; Osteocalcin; Parathyroid Hormone (PTH); Procalcitonin; Renin Activity; Renin (Direct Concentration)




PT-CL-CC-NB

Neonatal Bilirubin Bilirubin, direct; Bilirubin, total



PT-CL-CC-SFC

Spinal Fluid Chemistry

Albumin; Chloride; Glucose; lgG; Lactate; LDH; Potassium; Sodium; Total Protein

2ml simulated CSF



PT-CL-CC-TMS

Tumour Markers Beta 2 Microglobulin; CA-125; CA 15-3; CA 19-9; CA 27.29; NSE; PSA, free; Thyroglobulin




PT-CL-CC-UC

Urine Chemistry Albumin / Microalbumin; Albumin / Creatinine Ratio (ACR); Amylase; Calcium; Chloride; Creatinine; Glucose; Magnesium; Osmolality; Phosphate; Potassium; Sodium; Total Nitrogen; Total Protein; Urate; Urea

10ml urine 12 rounds (3 despatches,



PT-CL-CC-BLG

Blood Gas pCO2; pH; pO2; Bicarbonate (tCO2); Calcium, ionised; Chloride; Creatinine; Glucose; Lactate; Magnesium, ionised; Potassium; Sodium; Urea

3ml ampoule 12 rounds (2 despatches,


PT-CL-CC-BLX

Blood Oximetry Carboxyhaemoglobin; Haematocrit, calculated; Haemoglobin, total; Methaemoglobin; Oxyhaemoglobin

2ml ampoule Haemoglobin source is bovine



PT-CL-CC-CAR

Cardiac Markers BNP; CK-MB, activity; CK-MB, mass; Creatine Kinase (CK), total; D-dimer; Homocysteine; Myoglobin; NT pro-BNP; Troponin I; Troponin T




PT-CL-CC-GLH

Glycosylated Haemoglobin

Glycosylated haemoglobin (as HbA1c)

0.2ml lyophilised haemolysed human blood





of 20 V4


Application Form

HAEMATOLOGY (CLS) ACCREDITED BY A2LA

HAEMATOLOGY (CLS) ACCREDITED BY A2LA


PT-CL-HM-ABI

Advanced Blood Cell ID (online only)

Blood Cell Identification 7 x annotated cells/objects on a virtual slide

3 rounds (3 despatches, 1 round per

despatch)

PT-CL-HM-BID

Blood Cell ID and Differential (online only)

Blood Cell Identification; Neutrophils, segmented or band; Neutrophils, band; Neutrophils, segmented; Lymphocytes; Monocytes; Basophils; Eosinophils; Lymphocytes, reactive; Immature Cells; NRBCs per 100 WBCs; Platelet Estimate; Unclassified Cells

10 x annotated cells/objects on a virtual slide


despatch)

PT-CL-HM-BHM

Basic Haematology

Haemoglobin; Haematocrit; MCH; MCHC; MCV; MPV; Platelets; Plateletcrit; RBC; RDW CV; RDW SD; WBC

2ml simulated whole blood



PT-CL-HM-COA

Coagulation There are two levels of participation. Please see ‘Price’ column for further details.

APTT; Fibrinogen; INR; Prothrombin Time; Thrombin Time; Antithrombin III Activity; Factor II Activity; Factor V Activity; Factor VII Activity; Factor VIII Activity; Factor IX Activity; Factor X Activity; Factor XI Activity; Factor XII Activity; Plasminogen Activity; Protein C Activity; Protein S Activity

1ml lyophilised plasma



PT-CL-HM-HMX

5 Part Diff CBCX Haemoglobin; Haematocrit; MCH; MCHC; MCV; MPV; Platelets; RBC; RDW; WBC; Neutrophils; Lymphocytes; Monocytes; Eosinophils; Basophils; Neutrophils, absolute; Lymphocytes, absolute; Monocytes, absolute; Eosinophils, absolute; Basophils, absolute; Immature Granulocytes; Immature Granulocytes, absolute; Nucleated RBCs

2ml simulated whole blood

6 rounds (2 despatches, 3 rounds per

despatch)

PT-CL-HM-MP

Microscopy Package (online only)

Fecal WBC; Fern Test; Nasal Smear; Pinworm Preparation; Sperm; Urine Sediment; Vaginal Wet Preparation; Vaginal Wet Prep – KOH

9 x virtual images for microscopy


despatch)

PT-CL-HM-UA

Urinalysis and HCG

Bilirubin; Bilirubin, confirmatory; Blood/Haemoglobin; Creatinine; Glucose; hCG; Ketones; Leukocyte Esterase; Nitrite; pH; Protein; Protein, confirmatory; Reducing Substance; Specific Gravity; Urobilinogen

2 x 10ml urine 3 rounds (3 despatches, 1 round per

despatch)

#Participants select analytes at the point of results entry. The number of analytes that can be selected will be restricted based on your chosen level of participation.


PT-CL-HM-SR

Sedimentation Rate Sedimentation Rate 5ml simulated

whole blood 12 rounds

(4 despatches, 3 rounds per despatch)



of 20 V4


Application Form

IMMUNOLOGY (CLS) ACCREDITED BY A2LA

IMMUNOLOGY (SAR) NOT ACCREDITED


PT-CL-IM-HEP

Hepatitis Serology Anti-HAV, total; Anti-HAV, IgG; Anti-HAV, IgM; Anti-HBc, total; Anti-HBc, IgM; Anti-HBs; Anti-HCV; HBsAg



PT-CL-IM-HIV

HIV Serology Anti-HIV-1; Anti-HIV-2; Anti-HIV-1/2; HIV-1 p24 Antigen



PT-CL-IM-HS

High Sensitivity CRP C-Reactive Protein, hs 0.5ml serum 12 rounds


PT-CL-IM-IM

Infectious Mononucleosis

Infectious Mononucleosis 0.65ml serum 12 rounds (3 despatches,


PT-CL-IM-IPR

Immunoproteins / C3 and C4

Alpha1-acid-glycoprotein; Alpha1-antitrypsin (AAT); Alpha2-macroglobulin; Anti-Streptolysin O; Antithrombin III; Ceruloplasmin; Complement C3; Complement C4; C-Reactive Protein; Haptoglobin; IgA; IgE, total; IgG; IgM; Kappa Light Chain, free; Kappa Light Chain, total; Lambda Light Chain, free; Lambda Light Chain, total; Retinol Binding Protein; Rheumatoid Factor




PT-CL-IM-RUB

Rubella Rubella Antibody, IgG; Rubella Antibody, IgM



PT-CL-IM-SYP

Syphilis Serology Syphilis 1ml serum 12 rounds


PT-CL-IM-TA

Thyroid Antibodies Anti-TG; Anti-TPO

0.5ml serum 12 rounds (3 despatches,



PT-CL-MI-SAB

SARS-CoV-2 Serology

SARS-CoV-2 Antibody, total; SARS-CoV-2 Antibody, IgA; SARS-CoV-2 Antibody, IgG; SARS-CoV-2 Antibody, IgM

2 x 0.75ml plasma 3 rounds (3 despatches, 1 round per

despatch)



of 20 V4


Application Form

BACTERIOLOGY (CLS) ACCREDITED BY A2LA


PT-CL-MC-BAC-BASIC

Basic Bacteriology Package

Blood culture identification Blood culture susceptibility Throat culture identification Urine colony count Urine culture identification Urine culture susceptibility

3 x lyophilised swabs and/or lyophilised pellet in vials with diluent


despatch)

PT-CL-MC-BAC-COMP

Comprehensive Bacteriology

Includes all the above BAC-BASIC analytes and also:

CSF culture identification CSF culture susceptibility Ear/Eye culture identification Group B Strep culture N. gonorrhoeae culture Sputum culture identification Sputum culture susceptibility Stool culture identification Wound culture identification Wound culture susceptibility

4 x lyophilised swabs and/or lyophilised pellet in vials with diluent


despatch)

PT-CL-MC-BTP Bordetella pertussis/ parapertussis (molecular)

Bordetella pertussis; Bordetella parapertussis

2 x 1ml liquid samples


despatch)

PT-CL-MC-CDF C. difficile Toxin/Antigen

C. difficile Toxin; C. difficile Antigen



despatch)

PT-CL-MC-CGC C. trachomatis & N. gonorrhoeae

(molecular)

Chlamydia trachomatis; Neisseria gonorrhoeae



despatch)

PT-CL-MC-CRO

Carbapenem-Resistant Organisms

IMP; KPC; NDM; OXA-48; VIM 2 x lyophilised swabs


despatch)

PT-CL-MC-GBS

Group B Strep (molecular)

Group B Streptococcus 5 x lyophilized swabs


despatch)

PT-CL-MC-GSV

Gram Stain- Vaginitis (online only)

Bacterial vaginosis; Nugent Score

2 x virtual Gram stained slides


despatch)

PT-CL-MC-LG Legionella pneumophila Antigen

Legionella pneumophila Antigen 2 x 0.5ml liquid samples


despatch)

PT-CL-MC-MPG

Mycoplasma genitalium (molecular)

Mycoplasma genitalium 2 x 1ml liquid samples


despatch)

PT-CL-MC-MPM Mycoplasma pneumoniae (molecular)

Mycoplasma pneumoniae 2 x 1ml liquid samples


despatch)



of 20 V4


Application Form

BACTERIOLOGY (CLS) ACCREDITED BY A2LA

MYCOBACTERIOLOGY (CLS) ACCREDITED BY A2LA

MYCOLOGY (CLS) ACCREDITED BY A2LA


PT-CL-MC-MRM

Methicillin-Resistant/ Methicillin-Sensitive Staphylococcus aureus (molecular)

Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus

2 x lyophilized swabs


despatch)

PT-CL-MC-MRS

Methicillin-Resistant Staphylococcus aureus Culture

Methicillin-Resistant Staphylococcus aureus culture



despatch)

PT-CL-MC-SPN Streptococcus pneumoniae Antigen

Streptococcus pneumoniae Antigen 2 x 0.5ml liquid samples


despatch)

PT-CL-MC-SPY

Streptococcus Pharyngeal (molecular)

Group A Streptococcus; Group C/G Streptococcus



despatch)

PT-CL-MC-VGS

Gram Stain- Direct Smears (online only)

Gram Stain Interpretation; Leukocytes; Stain Quality; Sputum Specimen Quality

2 x virtual Gram stained slides


despatch)

PT-CL-MC-VRE

VRE Culture Vancomycin-Resistant Enterococcus 2 x lyophilized

swabs 3 rounds

(3 despatches, 1 round per despatch)

PT-CL-MC-VRM

VRE (molecular) Vancomycin-Resistant Enterococcus 2 x lyophilized

swabs 3 rounds



PT-CL-MC-AFB

Acid Fast Smears Acid Fast Bacilli Smear 3 x single-well

glass slides 3 rounds


PT-CL-MC-MTB

Mycobacteriology Culture

Mycobacteriology culture ID 3 x lyophilized loops and/ or liquid samples


despatch)

PT-CL-MC-MTM

Mycobacterium tuberculosis (molecular)

Mycobacterium tuberculosis complex;

Rifampin resistance 2 x 1ml liquid samples


despatch)


PT-CL-MC-MY

Mycology Culture Mycology culture ID 5 x lyophilized

swabs 3 rounds




of 20 V4


Application Form

PARASITOLOGY (CLS) ACCREDITED BY A2LA

VIROLOGY (CLS) ACCREDITED BY A2LA

VIROLOGY (SAR) NOT ACCREDITED


PT-CL-MC-BPS

Blood Parasites Blood parasite ID 3 x Giemsa stained

blood smears; 2 x virtual Giemsa stained blood smears


despatch)

PT-CL-MC-CRG

Giardia & Cryptosporidium Antigens

Cryptosporidium Antigen; Giardia Antigen



despatch)

PT-CL-MC-TCH Trichomonas vaginalis

Trichomonas vaginalis 3 x 2ml liquid samples


despatch)


PT-CL-MC-HPV

Human papillomavirus (molecular)

Human papillomavirus; HPV genotyping

5 x 1ml preservative solution with cells containing HPV


despatch)

PT-CL-MC-NOR

Norovirus (molecular)

Norovirus GI; Norovirus GII

2 x 1ml samples 3 rounds (3 despatches, 1 round per

despatch)

PT-CL-MC-ROT

Rotavirus Rotavirus 3 x 1ml liquid

samples 3 rounds


PT-CL-MC-VIR

Respiratory Virology

Adenovirus; Influenza A; Influenza B; Influenza A or B; Respiratory Syncytial Virus



despatch)

VIROLOGY (SAR) ACCREDITED BY UKAS


PT-CL-MI-COV

SARS-CoV-2 (Molecular)

SARS-CoV-2 (Molecular) 2 x 1.5ml samples 6 rounds (6 despatches, 1 round per

despatch)


PT-CL-MI-ATG

SARS-CoV-2 (Antigen)

SARS-CoV-2 (Antigen) 3 x swab based samples


despatch)



of 20 V4


Application Form

MOLECULAR MULTIPLEX (CLS) ACCREDITED BY A2LA

THERAPEUTIC DRUG MONITORING (TDM) ACCREDITED BY UKAS


PT-CL-MC-BCP

Blood Pathogen Panel (multiplex)

Identification of Bacteria Identification of Yeasts Resistance Genes



despatch)

PT-CL-MC-GIP

Gastrointestinal Panel (multiplex)

Identification of Bacteria Identification of Viruses Identification of Parasites


3 rounds (3 despatches, 1 round

per despatch)

PT-CL-MC-MEP

Meningitis Panel (multiplex)

Identification of Bacteria Identification of Viruses Identification of Yeasts



per despatch)

PT-CL-MC-PNE

Pneumonia Panel (multiplex)

Identification of Bacteria Identification of Viruses Resistance Genes

5 x 0.5 ml liquid samples


per despatch)

PT-CL-MC-RSP

Respiratory Panel (multiplex)

Identification of Bacteria Identification of Viruses



per despatch)


PT-TM-TD1

Therapeutic Drugs mixture

Carbamazepine; CBZ-epoxide; Carbamazepine+CBZ-epoxide; Clonazepam; Lamotrigine; Phenytoin; Ethosuximide; Phenobarbitone; Primidone; Valproate; Caffeine; Digoxin; Lithium; Theophylline; Methotrexate; Paracetamol (Acetaminophen); Salicylic Acid; TD-Amikacin; TD-Gentamicin; TD-Tobramycin; TD-Vancomycin

3 x 5ml samples of lyophilised human serum



PT-TM-CN1

Clobazam; Norclobazam

Clobazam; Norclobazam 2 x 2ml samples of lyophilised human serum



PT-TM-AE1

Anti-epileptic drugs mixture 1

OH-oxcarbazepine; Gabapentin; Tiagabine; Levetiracetam; Pregabalin

1 x 4ml sample of lyophilised human serum



PT-TM-AE2

Anti-epileptic drugs mixture 2

Topiramate; Vigabatrin; Felbamate; Zonisamide; Rufinamide; Lacosamide




PT-TM-CRD

Cardiac mixture Amiodarone; Desethylamiodarone; Flecainide






of 20 V4


Application Form

THERAPEUTIC DRUG MONITORING (TDM) NOT ACCREDITED

DRUGS FOR THE TREATMENT OF SUBSTANCE RELATED DISORDERS (TDM) ACCREDITED BY UKAS

PSYCHOACTIVE DRUGS (TDM) ACCREDITED BY UKAS


PT-TM-AE4

Anti-epileptic drugs 4

Perampanel 1 x 2ml sample of lyophilised human serum



PT-TM-AE5

Anti-epileptic drugs 5 Brivaracetam 1 x 2ml sample of

lyophilised human serum



PT-TM-AM1

Analgesic mixture Ibuprofen; Diclofenac; Tramadol 2 x 5ml sample of

lyophilised human serum


1 round per despatch)


PT-TM-SA01 Buprenorphine; Norbuprenorphine

2 x 2ml lyophilised human serum



PT-TM-SA02 Methadone; EDDP





PT-TM-PS01 Amitriptyline; Nortriptyline 5ml lyophilised newborn calf serum



PT-TM-PS02 Imipramine; Desipramine 5ml lyophilised newborn calf serum



PT-TM-PS03 Clomipramine; Norclomipramine 5ml lyophilised newborn calf serum



PT-TM-PS04 Clozapine; Norclozapine 5ml lyophilised human serum



PT-TM-PS05 Doxepin; Nordoxepin 5ml lyophilised newborn calf serum


despatch)

PT-TM-PS06 Fluoxetine; Norfluoxetine 5ml lyophilised newborn calf serum


despatch)

PT-TM-PS07 Fluphenazine 5ml lyophilised newborn calf serum


despatch)

PT-TM-PS08 Sertraline; Norsertraline 5ml lyophilised newborn calf serum


despatch)

PT-TM-PS09 Trimipramine; Nortrimipramine 5ml lyophilised newborn calf serum


despatch)



of 20 V4


Application Form



PT-TM-PS10 Risperidone; HO-risperidone 5ml lyophilised newborn calf serum


despatch)

PT-TM-PS11 Mirtazapine; Normirtazapine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS12 Maprotiline; Normaprotiline 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS13 Thioridazine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS14 Haloperidol 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS15 Olanzapine 5ml lyophilised human serum


per despatch)

PT-TM-PS16 Perphenazine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS17 Quetiapine; Norquetiapine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS18 Citalopram; Norcitalopram 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS19 Dothiepin; Northiaden 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS20 Venlafaxine; Norvenlafaxine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS21 Paroxetine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS22 Fluvoxamine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS23 Zuclopenthixol 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS24 Amisulpride 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS25 Aripiprazole; Dehydroaripiprazole 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS26 Ziprasidone 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS27 Duloxetine 5ml lyophilised newborn calf serum


per despatch)



of 20 V4


Application Form


PSYCHOACTIVE DRUGS (TDM) NOT ACCREDITED

PSYCHOSTIMULANTS (TDM) NOT ACCREDITED

SMOKING RELATED DRUGS (TDM) NOT ACCREDITED


PT-TM-PS28 Escitalopram 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS29 Trazodone 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS30 Sulpiride 5ml lyophilised newborn calf serum


per despatch)


PT-TM-PS31 Chlorpromazine; Norchlorpromazine 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS32 Mianserin 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS33 Brexpiprazole 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS34 Lurasidone 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS35 Sertindole 5ml lyophilised newborn calf serum


per despatch)

PT-TM-PS36 Iloperidone 5ml lyophilised newborn calf serum


per despatch)


PT-TM-PST1 Atomoxetine; Methylphenidate; Ritalinic acid



per despatch)


PT-TM-NC01 Nicotine; Cotinine

2 x 5ml lyophilised human urine


per despatch)



of 20 V4


Application Form

ANTI-HYPERTENSIVE DRUG SCREEN (TDM) NOT ACCREDITED

ANTIBIOTIC AND ANTIFUNGAL DRUGS (TDM-ANTIBIOTICS) ACCREDITED BY UKAS

ANTIBIOTIC AND ANTIFUNGAL DRUGS (TDM-ANTIBIOTICS) NOT ACCREDITED


PT-TM-AH01 Drug identification. Up to four drugs may be present in the sample, please see the Scheme description for further details

2 x 5ml lyophilised human urine


per despatch)


PT-AT-01 Gentamicin; Vancomycin 1ml human serum 12 rounds (12 despatches, 1 round

per despatch)

PT-AT-02 Tobramycin 1ml human serum 12 rounds (12 despatches, 1 round

per despatch)

PT-AT-03 Amikacin 1ml human serum 12 rounds (12 despatches, 1 round

per despatch)

PT-AT-07 Teicoplanin 1ml human serum 12 rounds (12 despatches, 1 round

per despatch)


PT-AT-08 Antibiotics 1.7ml human serum


per despatch)

PT-AT-AF01 Antifungals 1.7ml human serum


per despatch)



of 20 V4


Application Form

IMMUNOSUPPRESSANTS (IPT) ACCREDITED BY UKAS

*Labs will receive one set of samples for both Ciclosporin and Tacrolimus. You must be registered for the relevant analyte(s) in order to return results for assessment.

TOXICOLOGY (TOX) ACCREDITED BY UKAS


PT-IP-CIC Ciclosporin* 3 x 1ml liquid human blood


per despatch)

PT-IP-TAC Tacrolimus*

PT-IP-SIR Sirolimus 3 x 1ml liquid human blood


per despatch)

PT-IP-EVE Everolimus 3 x 1ml liquid human blood


per despatch)

PT-IP-MPA Mycophenolic acid 2 x 1ml liquid human plasma


per despatch)


PT-TX-SM Ethanol; Paracetamol (Acetaminophen); Salicylic Acid

3 x 1.7ml human serum


per despatch)

PT-TX-BLD Ethanol; Paracetamol (Acetaminophen); Salicylic Acid; Carboxyhaemoglobin

1.7ml liquid human blood


per despatch)

PT-TX-URN Ethanol 1.7ml liquid human urine


per despatch)

PT-TX-CAS Participants should report results, toxicological involvement and treatment options

1 x Serum Sample; 1 x Urine Sample + Scenario


per despatch)

PT-TX-TAK Ethanol; Methanol; Isopropylalcohol (IPA); Acetone Ethylene Glycol

1.7ml liquid blood 2 rounds (2 despatches, 1 round

per despatch)

PT-TX-TAS Ethanol; Methanol; Isopropylalcohol (IPA); Acetone; Ethylene Glycol

1.7ml liquid serum 2 rounds (2 despatches, 1 round

per despatch)

PT-TX-GHB Gammahydroxybutyrate 3 x 2ml lyophilised human urine


per despatch)

PT-TX-BNZ Diazepam; Nordazepam; Temazepam; Oxazepam; Nitrazepam



per despatch)

PT-TX-BNZB Alprazolam; Bromazepam; Clonazepam; Lorazepam; Midazolam



per despatch)

PT-TX-QT Participants should report quantitative data on specified analytes

2 x 10ml liquid human blood


per despatch)



of 20 V4


Application Form

TOXICOLOGY (TOX) NOT ACCREDITED

DRUGS OF ABUSE IN URINE (DAU) ACCREDITED BY UKAS

Full Full participants will be able to report for the screening only analytes using immunoassay type techniques and individual analytes by chromatography type techniques. Approximately 210 individual analytes are available and are managed by your PORTAL online screening profile. Participants will receive 3 freeze-dried urine samples, each with a volume of 15ml.

Screening-only This is designed for participants who report using immunoassay type techniques, including POCT (point of care testing). Participants will receive 3 freeze-dried urine samples, each with a volume of 15ml. The screening groups are as follows: Amfetamine screen Methadone screen Barbiturate screen Methamfetamine screen Benzodiazepine screen Opiate screen Buprenorphine screen Phencyclidine screen Cannabinoid screen Propoxyphene screen Cocaine screen Tricyclic screen LSD screen

Please note that it is not possible to report on individual analytes if participating on a Screening-only basis.

DRUGS OF ABUSE IN ORAL FLUID (DOF) ACCREDITED BY UKAS


PT-TX-ZMIX Zolpidem; Zaleplon; Zopiclone 2 x 4ml lyophilised human serum


per despatch)

Sample Rounds per annum Please tick

Full PT-DU-FULL-W

4 rounds (4 despatches, 1 round per despatch)

Screening only PT-DU-SCREEN-W

4 rounds (4 despatches, 1 round per despatch)

Sample Sample details Supplied as Rounds per annum Please tick

OF1, OF2 and OF3

PT-DO-OF

Participants report on the major misused drug groups, reporting ‘detected or “not detected” to scheme thresholds.

3 x 1.7 mL oral fluid obtained from volunteers and known drug users


per despatch)



of 20 V4


Application Form

SHIPPING DATES

Code Programme 2020 2021

CLINICAL CHEMISTRY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

ALM Alcohol/Ammonia 18 24 20

BLG Blood Gas 14 21

BLX Blood Oximetry 18 24 20

CAR Cardiac Markers 14 21

CHM Chemistry / Immunoassay 14 21

GLH Glycosylated Haemoglobin 14 21

IAS Immunoassay - Special 18 24 20

NB Neonatal Bilirubin 18 24 20

SFC Spinal Fluid Chemistry 18 05

TMS Tumor Markers 14 21

UC Urine Chemistry 18 24 11

HAEMATOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

ABI Advanced Blood Cell ID 14 19 23

BID Blood Cell ID and Diff. 14 19 23

BHM Basic Haematology 18 19 05 11

COA Coagulation 18 05

HMX 5 Part Diff CBCX 01 23

MP Microscopy Package 14 19 23

SR Sedimentation Rate 14 01 21 20

UA Urinalysis and HCG 14 19 23

IMMUNOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

HEP Hepatitis Serology 14 21

HIV HIV Serology 14 21

HS High Sensitivity CRP 14 19 23

IM Infectious Mononucleosis 14 19 23

IPR Immunoproteins / C3 & C4 14 21

RUB Rubella 14 19 23

SAB SARS-CoV-2 Serology 29 26 29

SYP Syphilis Serology 14 19 23

TA Thyroid Antibodies 14 19 23

BACTERIOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

BAC-B Basic Bacteriology 14 19 23

BAC-C Comprehensive Bacteriol. 14 01 19 05 23 11

BTP Bordetella pertussis, etc 01 05 11

CDF C. difficile Toxin/Antigen 01 05 11

CGC C.trachomatis&N.gonorrh. 01 05 11

CRO Carbapen.-Res.Organisms 01 05 11

GBS Group B Strep - molecular 01 05 11

GSV Gram Stain – Vaginitis 14 19 23

LG Legionella pneumo.Antigen 01 05 11

MPG Mycoplasma genitalium 01 05 11

MPM Mycoplasma pneumoniae 01 05 11

MRM MRSA - molecular 01 05 11

MRS MRSA Culture 01 05 11



of 20 V4


Application Form

SHIPPING DATES


BACTERIOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

SPN Streptococcus pneumoniae Antigen

01 05 11

SPY Streptococcus Pharyngeal - molecular

01 05 11

VGS Gram Stain - Direct Smear 14 19 23

VRE Vancomycin-Resistant Enterococcus Culture

01 05 11

VRM Vancomycin-Resistant Enterococcus - molecular

01 05 11

MYCOBACTERIOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

AFB Acid Fast Smears 01 05 11

MTB Mycobacteriology Culture 01 21 20

MTM Mycobacterium tuberculosis - molecular

01 05 11

MYCOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

MY Mycology Culture 14 01 05

PARASITOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

BPS Blood Parasites 01 05 11

CRG Giardia & Crypto. Antigens 01 05 11

TCH Trichomonas vaginalis 01 05 11

VIROLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

ATG SARS-CoV-2 - Antigen 25 29 24 26 27 29

COV SARS-CoV-2 - Molecular 25 29 24 26 27 29

HPV Human Papillomavirus - molecular

01 05 11

NOR Norovirus - molecular 01 05 11

ROT Rotavirus 01 05 11

VIR Respiratory Virology 01 05 11

MOLECULAR MULTIPLEX Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

BCP Blood Pathogen Panel 01 05 11

GIP Gastrointestinal Panel 01 05 11

MEP Meningitis Panel 01 05 11

PNE Pneumonia Panel 01 05 11

RSP Respiratory Panel 01 05 11

THERAPEUTIC DRUG MONITORING Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

TDM All apart from Antibiotics 18 19 26 18

ANT Antibiotic&Antifungal drugs 11 08 08 06 04 01 05 02 06 04 01 06

IMMUNOSUPPRESSANTS Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

CIC/TAC Ciclosporin and Tacrolimus 18 15 15 12 10 07 12 09 13 11 15 13

SIR Sirolimus 18 15 15 12 10 07 12 09 13 11 15 13

EVE Everolimus 18 15 10 12 13 15

MPA Mycophenolic acid 18 15 10 12 13 15



of 20 V4


Application Form

SHIPPING DATES

REPEAT/ADDITIONAL SAMPLES

Please note that any additional or repeat samples can be ordered, please contact LGC Proficiency Testing for prices.

For additional samples, please state clearly your requirements below.


TOXICOLOGY Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

SM Serum - Quantitative 11 15 15 12 10 07 12 09 13 04 08 13

BLD Blood - Quantitative 11 15 15 12 10 07 12 09 13 04 08 13

URN Urine - Ethanol 11 15 15 12 10 07 12 09 13 04 08 13

CAS Toxicology case studies 15 10 09 08

TAK Toxic alcohols in blood 10 08

TAS Toxic alcohols in serum 11 12

GHB GHB in urine 10 08

QT Whole blood quant. tox. 11 12 12 04

BNZ Benzodiazepine Mix 1 15 07 13 13

BNZB Benzodiazepine Mix B 15 10 09 08

ZMIX Z-Drug Mix 15 07 13 13

DRUGS OF ABUSE Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

DAU Drugs of Abuse in Urine 11 19 26 18

DOF Drugs in Oral Fluid 01 07 20 08



of 20 V4


Application Form

GENERAL NOTES Please note:

Please contact LGC Proficiency Testing for prices.

VAT (charged at the prevailing rate) is payable by all participants based in the UK.

Participants will pay an additional fee to cover courier charges. Please contact LGC Proficiency Testing for up-to-date charges.

Courier charges will be charged per scheme and per despatch date.

All courier charges set by LGC Proficiency Testing do not include local import charges, taxes (etc.), which will be covered by the participant.

No refunds will be given for failure to take part in any round of the PT scheme.

LGC Proficiency Testing reserves the right to not send samples or the report for previous samples to any participant that has not paid their subscriptions within the terms stated on the invoice.

LGC Proficiency Testing cannot guarantee the number of participants that will return results for any particular parameter in each round.

The prices stated are for reporting results and receiving reports electronically via PORTAL (internet reporting). If alternative data entry or reporting methods are required, further charges apply. Please contact LGC Proficiency Testing for the current charges.

Please note that the prices for the programmes listed on pages 3-9 allow the submission of 5 nominated results (e.g. for 5 different instruments), where sample volume allows. The prices for the programmes listed on pages 10-15 allow the submission of 3 nominated results (e.g. for 3 different instruments), where sample volume allows. In addition, 10 non-nominated results can be submitted. Should your laboratory have a requirement to submit additional results, further charges apply. Please contact LGC Proficiency Testing for the current charges.

The scheme reports the performance of U.K. participants who are involved in patient care to the National Quality Assurance Advisory Panels for Chemical Pathology and for Medical Microbiology.

Clinical 2021 - Amazon Web Services

Documents

Transcript of Clinical 2021 - Amazon Web Services